OTIMIX, Ušní kapky, suspenze
OTIMIX, Ušní kapky, suspenze
Not authorised
- Prednisolone acetate
- POLYMYXIN B SULFATE
- Miconazole nitrate
Product identification
Medicine name:
OTIMIX, Ušní kapky, suspenze
Active substance:
- Prednisolone acetate
- POLYMYXIN B SULFATE
- Miconazole nitrate
Target species:
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Prednisolone acetate5.00/milligram(s)1.00millilitre(s)
-
POLYMYXIN B SULFATE5500.00/international unit(s)1.00millilitre(s)
-
Miconazole nitrate23.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Withdrawal period by route of administration:
-
Auricular use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Czechia
Package description:
- Available only in Czech
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/028/15-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?: